UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2014

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ______________ to ______________

SEC file number 333-163035

Hyperera, Inc.

(Name of small business issuer in our charter)

Nevada

7370

26-2007556

(State or other jurisdiction of

incorporation or organization)

(Primary Standard Industrial

Classification Code Number)

IRS I.D.

2316 S Wentworth Ave Chicago, IL		60616
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number: 312-842-2288

N/A

(Former name, former address and former phone number, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and 2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller Reporting Company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of September 30, 2014 there were 40,104,000 shares issued and outstanding of the registrant’s common stock.

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION

Item 1.	Financial Statements.	3
Item 2.	Management’s Discussion and Analysis or Plan of Operation.	23
Item 3.	Quantitative and Qualitative Disclosure about Market Risk.	31
Item 4.	Controls and Procedures.	31

PART II — OTHER INFORMATION

Item 1.	Legal Proceedings.	32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	32
Item 3.	Defaults Upon Senior Securities.	32
Item 4.	Mine Safety Disclosures.	32
Item 5.	Other Information.	32
Item 6.	Exhibits.	33

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

HYPERERA, INC.

(A Development Stage Enterprise)

Financial Statements

(Unaudited)

As of September 30, 2014

Table of Contents

Consolidated Balance Sheet	5

Consolidated Statement of Operation		6

Statement of Shareholders Equity		7

Consolidated Statement of Cash Flow		8

Notes to Consolidated Financial Statements		9

Exhibit A		22

HYPERERA, INC

(A Development Stage Enterprise)

CONSOLIDATED BALANCE SHEETS (Unaudited)

				September 30			December 31
				2014			2013
ASSETS
	Current assets:
		Cash and cash equivalents		$	117,252			$	129,009
			Total Current Assets	$	117,252			$	129,009

	Other current assets:
		Prepaid Expenses		$	75,158			$	10,328
		Loans to related supplier			-				135,232
		Accrued interest			-				1,762
			Total Other Current Assets	$	75,158			$	147,322

	Fixed assets:
		Furniture & Equipment, Net		$	19,722			$	31,543
			Total Fixed Assets	$	19,722			$	31,543

	Other assets:
		Loans to Greensaver Corp			1,530,397				1,538,462
			Total Other Assets	$	1,530,397			$	1,538,462

			TOTAL ASSETS	$	1,742,529			$	1,846,336

LIABILITIES & EQUITY
	Current liabilities:
		Account payable		$	29,900			$	1,800
		Loan from shareholders			429,889				3,346
		Loan from others			141,712				241,734
		Payroll liabilities			967				1,188
			Total current liabilities	$	602,468			$	248,068

	Stockholders' Equity:
		Common stock, $0.001 par value; 200,000,000 shares authorized;40,104,000 shares issued and outstanding.		$	40,104			$	40,104
		Paid-in capital			2,722,464				2,722,464
		Deficit accumulated during the development stage			(1,313,046	)			(856,211	)
		Accumulated other comprehensive income (loss)			(309,461	)			(308,089	)
			Total stockholders' equity	$	1,140,061			$	1,598,268
			TOTAL LIABILITIES & EQUITY	$	1,742,529			$	1,846,336

HYPERERA, INC

(A Development Stage Enterprise)

CONSOLIDATED STATEMENT OF LOSS

(Unaudited)

															Cumulative from
															February 19,
			Three			Three			Nine			Nine			2008 (Date of
			Months			Months			Months			Months			Inception)
			Ended			Ended			Ended			Ended			Through
			September 30			September 30			September 30			September 30			September 30
			2014			2013			2014			2013			2014
Revenues			$	13,786		$	-		$	13,786		$	-		$	242,644
Cost of Goods Sold				3,852			-			3,852			-			211,850
Gross Profit			$	9,934		$	-		$	9,934		$	-		$	30,794
Operating expenses:
	Selling, general and administrative expenses			171335			124,506			454,368			248,379			1,738,176
	Depreciation and amortization expenses			4385			4,385			13,155			12,073			51,276
		Total Operating Expenses	$	175,720		$	128,891		$	467,523		$	260,452		$	1,789,452

	Operating Loss		$	(165,786	)	$	(128,891	)	$	(457,589	)	$	(260,452	)	$	(1,758,658	)

Investment income, net			$	558		$	39,536		$	1,868		$	117,504		$	446,988
Interest Expense, net				-			-			734			-			1,001
Loss before income taxes				(165,228	)		(89,355	)		(456,455	)		(142,948	)		(1,312,671	)
Loss tax expense				375			-			375			-			375
Net Loss			$	(165,603	)	$	(89,355	)	$	(456,830	)	$	(142,948	)	$	(1,313,046	)

Net loss per common share- Basics			$	(0.00	)	$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.03	)
Net loss per common share- Diluted			$	(0.00	)	$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.03	)

Other comprehensive loss, net of tax:
	Uncollectible interest receivable write off			-			-			-			-			(339,726	)
	Foreign currency translation adjustments			(548	)		(27	)		(1,373	)		796			30,265
		Other comprehensive loss	$	(548	)	$	(27	)	$	(1,373	)	$	796		$	(309,461	)
Comprehensive Loss			$	(166,151	)	$	(89,382	)	$	(458,203	)	$	(142,152	)	$	(1,622,507	)

HYPERERA, INC

(A Development Stage Enterprise)

STATEMENT OF STOCKHOLDERS EQUITY

The Period February 19, 2008 ( Date of Inception) through September 30, 2014

(Unaudited)

							Deficit
							Accumulated			Accumulated
					Additional		During the			Other			Total
	Common Stock				Paid-in		Development			Comprehensive			Stockholders'
	Shares		Amount		Capital		Stage			Income (Loss)			Equity
Balance, December 31, 2008		27,939,000	$	27,939	$	230,231	$	(51,611	)	$	(311	)	$	206,248

Balance, December 31, 2009		27,999,000	$	27,999	$	242,171	$	(90,244	)	$	(453	)	$	179,473

Balance, December 31 , 2010		35,984,000	$	35,984	$	1,831,186	$	(281,478	)	$	22,561		$	1,608,253

Balance, December 31 , 2011		38,204,000	$	38,204	$	2,344,364	$	(395,763	)	$	28,739		$	2,015,544

Adjustment for Rate Exchange		-		-		-		-		$	(459	)	$	(459	)

Net loss for the period ended December 31, 2012		-		-		-	$	(200,249	)		-		$	(200,249	)
Balance, December 31 , 2012		38,204,000	$	38,204	$	2,344,364	$	(596,012	)	$	28,280		$	1,814,836

Issuance of common stocks to shareholder @0.2 per share on July 01, 2013		400,000	$	400	$	79,600		-			-		$	80,000

Issuance of common stocks to shareholders @0.20 per share on August 30, 2013		1,500,000	$	1,500	$	298,500		-			-		$	300,000

Adjustment for Rate Exchange		-		-		-		-		$	3,357		$	3,357

Write off Interest Receivable		-		-		-		-		$	(339,726	)	$	(339,726	)

Net loss for the period ended December 31, 2013		-		-		-	$	(260,199	)		-		$	(260,199	)
Balance, December 31, 2013		40,104,000	$	40,104	$	2,722,464	$	(856,211	)	$	(308,089	)	$	1,598,268

Adjustment for Rate Exchange		-		-		-		-		$	(824	)	$	(824	)

Net loss for the period ended June 30, 2014		-		-		-	$	(291,232	)		-		$	(291,232	)
Balance, June 30, 2014		40,104,000	$	40,104	$	2,722,464	$	(1,147,443	)	$	(308,913	)	$	1,306,212

Adjustment for Rate Exchange		-		-		-		-		$	(548	)	$	(548	)

Net loss for the period ended September 30, 2014		-		-		-	$	(165,603	)		-		$	(165,603	)
Balance, September 30, 2014		40,104,000	$	40,104	$	2,722,464	$	(1,313,046	)	$	(309,461	)	$	1,140,061

HYPERERA, INC

(A Development Stage Enterprise)

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

													Cumulative from
													February 19,
	Three			Three			Nine			Nine			2008 (Date of
	Months			Months			Months			Months			Inception)
	Ended			Ended			Ended			Ended			Through
	September 30			September 30			September 30			September 30			September 30
	2014			2013			2014			2013			2014
Operating Activities:
Net Loss	$	(165,603	)	$	(89,355	)	$	(456,830	)	$	(142,948	)	$	(1,313,046	)
Adjustments to reconcile net income to net cash provided by operating activities:
Non-cash portion of share based legal fee expense		-			-			-			-			4,170
Non-cash portion of share based consulting fee expense					-						-			20,000
Depreciation		4,385			4,385			13,155			12,073			51,276
Inventory		5,514			-			-			-			-
Accrued interest receivable		3,033			(39,478	)		1,762			(40,494	)		-
Prepaid Expense		(24,594	)		(5,437	)		(64,829	)		(5,437	)		(75,158	)
Account payable		2,100			2,100			28,100			(400	)		29,900
Payroll liabilities		(429	)		(5,391	)		(221	)		764			967
Loans from Others		-			170,022			(100,022	)		235,489			141,712
Loan from shareholders		76,307			13,899			426,543			(12,268	)		429,889
Net cash provided by operating activities	$	(99,287	)	$	50,745		$	(152,342	)	$	46,779		$	(710,290	)

Investing Activities:
Purchase Furniture & Equipment		-			(13,866	)		(1,334	)		(16,193	)		(70,997	)
Net cash provided by investing activities	$	-		$	(13,866	)	$	(1,334	)	$	(16,193	)	$	(70,997	)

Financing Activities:
Proceeds from issuance of common stock		-			380,000			-			380,000			2,738,398
Prepaid for stock purchase		-			(76,923	)		-			-			-
Loans Greensaver Corp		8,064			-			8,064			-			(1,530,398	)
Loans to related supplier		72,079			(172,415	)		135,232			(177,834	)		-
Net cash provided by financing activities	$	80,143		$	130,662		$	143,296		$	202,166		$	1,208,000

Effect of Exchange Rate on Cash	$	(548	)	$	(27	)	$	(1,373	)	$	796		$	30,265
Uncollectible interest receivable write off	$	-		$	-		$	-		$	-		$	(339,726	)

Net increase (decrease) in cash and cash equivalents	$	(19,692	)	$	167,514		$	(11,753	)	$	233,548		$	117,252
Cash and cash equivalents at beginning of the period	$	136,944		$	100,930		$	129,005		$	34,896		$	-
Cash and cash equivalents at end of the period	$	117,252		$	268,444		$	117,252		$	268,444		$	117,252

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

NOTE A - BUSINESS DESCRIPTION

Hyperera, Inc. (the “Company”), incorporated under the laws of Nevada on February 19, 2008. Hyperera, Inc. operates its business in the U.S. as Hyperera USA, Inc. the Company’ s wholly owned branch located in the State of Illinois and has principal office at 2316 South Wentworth Avenue, Chicago, IL 60616.

In addition to the U.S. operation, the Company had one representative office in China, which was established on April 2, 2008; the representative office was closed effective on July 1, 2009. In order to developing and operating more efficiently, in the mean time, Hyperera, Inc established a subsidiary Hyperera Technology (Beijing) Co, Ltd in China in July 3, 2009 to replace the representative office to conduct and operate the business of trading services, distribution, and marketing of the surgery anesthesia clinic management software and ICU management system software and hardware system in Asia.

Hyperera Technology (Beijing) Co, Ltd, as the wholly owned subsidiary, is registered on July 3, 2009 in China. Hyperera Technology (Beijing), Ltd is located at Room 11A, Block B, Kingwing Hotel, No. 17 Dongsanhuan South Road, Chaoyang District, Beijing, China 100021.

Hyperera, Inc. is headquartered in 2316 South Wentworth Avenue, Chicago, IL 60616, USA. The telephone number is 312-842-2288.

Hyperera Inc is a high-tech enterprise specialized in the surgery anesthesia clinic management software and intensive care unit (ICU) management system, control software research, development, software maintenance, upgrade and services. Our business is the sale of the surgery anesthesia clinic management software and ICU management system in Asia, and North America.

The surgery anesthesia clinic management software and ICU management system software is developed in China by Beijing Chaoran Chuangshi Technology Co., Ltd (“Beijing Chaoran”). It was established in 2002 specializing in technology developed and service, sales of computer hardware and software, machine and electric equipment. Beijing Chaoran Chuangshi Technology Co. is located in No.28 Mujiu Road, Mujiayu Town, Miyun, Beijing, China. On March 1^st, 2008, Hyperera, Inc. signed a long-term distribution agreement with Beijing Chaoran Chuangshi Technology Co. Beijing Chaoran Chuangshi Technology Co is a Chinese Technology company owned 100% by Mr.Liancheng Li, a Chinese national, the founder of the company.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES

Basis of accounting

The financial statements reflect the assets, revenues and expenditures of the Company on the accrual basis of accounting. The Company’s fiscal year end is December 31.

Principles of Consolidation

The consolidated financial statements of the Company include the accounts of Hyperera, Inc., and Hyperera Technology (Beijing) Co.., Ltd. All significant intercompany balances and transactions have been eliminated in consolidation

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect certain amounts reported in the financial statements and disclosures. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly-liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2014 there were $ 117,255 cash and cash equivalents.

Foreign Currency Translation

The Company has determined the United States dollars to be its functional currency for Hyperera USA, Inc; People’s Republic of China Chines Yuan Renminbi to be its functional currency in Hyperera BeiJing office. Assets and liabilities were translated to U.S. dollars at the period-end exchange rate. Statement of operations amounts were translated to U.S. dollars using the first date of each month during the year. Gains and losses resulting from translating foreign currency financial statements are accumulated in other comprehensive income (loss), a separate component of shareholders’ equity.

Stock-Based Compensation

The Company accounts for stock issued for services using the fair value method. In accordance with FASB ASC 505, the measurement date of shares issued for services is the date at which the counterparty’s performance is complete.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

Property, Plant, and Equipment Depreciation

Property, plant, and equipment are stated at cost. Depreciation is being provided principally by straight line methods with mid-month convention over the estimated useful lives of the assets. As of September 30, 2014, the net fixed assets were $ 19,722 in the Company’s balance sheets. The straight line depreciation methods over 7 years for furniture and 5 years for computers were used to calculate depreciations.

Net Loss Per Common Share

Basic EPS is computed by dividing the income (loss) available to Common Shareholders by the weighted-average number of common shares outstanding for the period. Diluted EPS is based on the weighted-average number of shares of common stock and common stock equivalents outstanding during the periods.

The Company only issued one type of shares, i.e., common shares only. There is no other type of securities issued. Accordingly, the diluted net loss and basic net loss per common share are the same.

Concentration of credit risk

The Company maintains its cash in bank accounts which, at times, may exceed the federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.

Loans to Greensaver Corporation

On April 15, 2012, the Company through its subsidiary Hyperera Technology (Beijing) Co., Ltd. signed a loan agreement with Greensaver Corporation, to advance a loan amount of $1,538,462 [10,000,000 RMB] at an annual interest rate of 10%. Greensaver Corporation is a silicon battery manufacturer located in 8 North Yangzijinag Rd, Ningbo, Zhejiang, China. The Company is in reorganization under the local Chinese laws. The loan agreement was amended on March 2013 to provide for a monthly payment of $80,645 starting July 1, 2013 and continuing until the loan is paid off by July 2015. Due to the reorganization of the Greensaver Corporation, the risk of default for our loan to Greensaver is high. If the loan is at default by Greensaver, our Company may have going concern. In fact the default occurred and the loan had to be restructured again.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

Loans to Greensaver Corporation (Continued)

On March 25, 2014, Loan Supplementary Agreement III was signed by Hyperera Technology (Beijing) Co., Ltd. and Greensaver Corporation. In the supplementary agreement, Greensaver promised to pay back RMB 50,000 in the 2^nd quarter of 2014, pay back RMB 150,000 in 3^rd quarter of 2014, and pay back RMB 300,000 in the 4^th quarter of 2014; then pay back RMB 2.5 million quarterly in year 2014. Based on the legal opinion of local Chinese law firm, United Law Office, Beijing China, the principal of loan amount of $1,538,462 [10,000,000 RMB] shall be protected by Chinese law but the interest of loan. If there is a lawsuit between Hyperera (Beijing) and Greensaver, in many Chinese court cases based on the legal opinion, the interest of loan shall not be held lawful by Chinese courts. Accordingly, the accumulated interest receivable of $ 339,726 was written off at December 31, 2013, and there’s no interest receivable was record and RMB 50,000 was returned on August 2014; therefore, there’s outstanding loan of $ 1,530,397 as of September 30, 2014.

Revenue Recognition

In accordance with the FASB ASC 985-605-25-3 Software Revenue Recognition if the arrangement does not require significant production, modification, or Customization of software, revenue shall be recognized when all of the following criteria are

The Company recognizes sales revenue for hardware, software and customized clinical information systems sales when it is realized or realizable and earned.

(1) Sales of Hardware

For most of the Company’s hardware product sales, these criteria are met at the time the product is shipped. The Company recognizes revenue from the sale of hardware products, and software bundled with hardware that is essential to the functionality of the hardware sold by the Company in accordance with general revenue recognition accounting guidance based on guidance in FASB ASC 605-25.

For the fiscal quarter ended September 30, 2014 and 2013, there were no hardware sales.

For the year 2010, the total hardware sales was $162,840, there was no any software bundle with the hardware sold in 2010.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

No hardware sales since 2010.

(2) Sales of Software

In accordance with FASB ASC 605-25 and FASB ASC 985-605-25, “Revenue Recognition,” the Company recognizes software sales revenue when it is realized or realizable and earned. Revenue is realized or realizable when the product is exchanged for cash or for claim to cash or other assets that are readily convertible into known amount of Cash.

The Company must meet all of the following four criteria under FASB ASC 605-25 and FASB ASC 985-605-25 to recognize software revenue.

	·	Persuasive evidence of an arrangement exists
	·	Delivery has occurred
	·	The vendor’s fee is fixed or determinable
	·	Collectability is probable.

The Company recognizes revenue in accordance with industry specific software accounting guidance for the following types of sales transactions: (i) standalone sales of software products, (ii) sales of software upgrades and (iii) sales of software bundled with hardware not essential to the functionality of the hardware.

(3) Multiple-element Arrangement for Sales of Hardware, Software and CIS:

We currently recognize multiple-element sales revenue pursuant to FASB ASC Topic 985-605 Software, Revenue Recognition, or ASC 985-605. We generate revenue from the sale of our software products sold directly to end-users. We also generate revenue from sales of hardware and third party software, implementation, training, software customization, post-contract support (maintenance). A typical system contract contains multiple elements of the above items. FASB ASC Topic 985-605-25, Software, Revenue Recognition, Multiple Elements, or ASC 985-605-25, as amended, requires revenue earned on software arrangements involving multiple elements to be allocated to each element based on the relative fair values of those elements. The fair value of an element must be based on vendor specific objective evidence ("VSOE"). We limit our assessment of VSOE for each element to either the price charged when the same element is sold

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

Revenue Recognition (Continued)

separately or the price established by management having the relevant authority to do so, for an element not yet sold separately. VSOE calculations are updated and reviewed at the end of each quarter or annually depending on the nature of the product or service.

In accordance with paragraph 4-14 of FASB ASC 605-45, "Reporting Revenues Gross as a Principal versus Net as an Agent", the Company will recognize revenues on a gross basis. ASC 605-45 discusses whether revenues and cost of goods sold to arrive at gross profit and their corresponding assets and liabilities should be recorded at gross or net.

The following indicators of gross revenue recognition are applicable in the Company:

	·	Acts as principal in the transaction.
	·	Has risk and rewards of ownership, such as risk of loss for collection, delivery and returns, and
	·	Takes title to the products,
	·	Flexibility in pricing
	·	Assumes credit risk;
	·	The company can change the products or perform part of the service, and the Company customizes the supplier’s software based on customer’s needs.

All the indicators of net revenue reporting (ASC 605-45, paragraph 16-23) are not applicable in the Company.

For the fiscal quarter ended September 30, 2014 and 2013, there were $ 16,405 & $ 0.00 software sales and software revenue realized for the Company.

Cost of Goods Sold

For the fiscal quarter ended September 30, 2014, and 2013 there was $3,852 & $ 0.00 cost of goods sold incurred.

Inventory

As of September 30, 2014, the Company have no inventory in stock.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

Operating Expenses

Operation expenses include selling, general & administrative expenses and depreciation & amortization expenses.

For the fiscal quarter end September 30, 2014 and 2013, there are total of $175,720 and $128,891 operating expenses respectively.

For the nine months period end September 30, 2014 and 2013, there are total of $467,523 and $260,452 operating expenses respectively. The selling, general and administrative expenses and depreciation details were showed in the Exhibit A.

Operating Leases

The Company entered into three leases for its corporate offices under terms of non-cancelable operating leases. The first lease term is from March 1, 2014 through February 28, 2015 and requires a $600 monthly lease payment. This office space is the corporate office of US, and is leased from a related party, which is the Company’s officer Simon Bai. For the fiscal quarter ended September 30, 2014 and 2013, there were $1,800 rent expenses incurred.

The second lease is the administration office space for China’s subsidiary in Beijing located at Room 11A, Block B, Kingwing Hotel, No. 17 Dongsanhuan South Road, Chaoyang District, Beijing, China 100021. The lease term runs from March 25, 2013 through March 24, 2015 and required a RMB 24,731.76 monthly lease payment. The third lease is the development and research, sales and marketing office space for China’s subsidiary in Beijing located at Room 7B, Block B, Kingwing Hotel, No. 17 Dongsanhuan South Road, Chaoyang District, Beijing, China 100021. The lease term runs from August 11, 2013 through August 10, 2014 and required a RMB 19,437.62 monthly lease payment. For the fiscal quarter ended September 30, 2014, and 2013, there was USD $ 21,372, and $ 14,133 rent expenses incurred correspondingly for China offices.

Therefore, there was total of $23,172 and $15,933 rent expenses for the fiscal quarter ended September 30, 2014 and 2013.

For the nine months period ended September 30, 2014 and 2014, the Company incurred a total of $69,517 and $40,521 rent expense respectively.

For the period of February 19 2008 to September 30, 2014, there’s a total of $292,171 rent expense was recorded.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE B - SIGNIFICANT ACCOUNTING POLICIES (Continued)

Professional Fee

Professional fees are included accounting and auditing fee, consulting fee, legal fee, SEC filing expenses, and other professional fees. For the fiscal quarter ended September 30 2014 and 2013, the Company incurred $14,681 and $ 5,530 respectively.

For the nine months period ended September 30 2014 and 2013, the Company incurred $56,426 and $ 50,386 respectively. For the cumulative period from February 19, 2008 to September 30, 2014, the company has professional fees of $ 484,303.

Comprehensive Income (Loss)

The company’s comprehensive income (loss) is comprised of net income (loss), unrealized gains and losses on marketable securities classified foreign currency translation adjustments, and unrealized gains and losses on derivative financial instruments related to foreign currency hedging, and the write off of the uncollectible interest receivable. Based on the legal opinion of local Chinese law firm, United Law Office, Beijing China, as Greensaver is in reorganization under the local Chinese laws, If there is a lawsuit between Hyperera (Beijing) and Greensaver, the principal of loan amount of $1,538,462 [10,000,000 RMB] shall be protected by Chinese law but not the interest of loan. Accordingly, the accumulated interest receivable of $339,726 from Greensaver was written off at December 31, 2013.

For the fiscal quarter ended September 30, 2014, and 2013, the company has $545 and $27 comprehensive loss respectively.

For the nine months period ended September 30, 2014, and 2013, the company has $1,373 comprehensive loss and $ 796 comprehensive income respectively. For the cumulative period from February 19, 2008 to September 30, 2014, the company has accumulated comprehensive loss of $309,462.

Income Tax

The Company filed extension for corporate tax return Form 1120 to Internal Revenue Service and IL 1120 to the State of Illinois for the year 2013. There is no income tax for the State of Nevada.

Hyperera Technology (Beijing) Co., Ltd. Filed annual report to Beijing local tax bureau, and no income tax dues were paid to Chinese government.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

New Pronouncement:

Pronouncement	Issued	Title
ASC 855	May 2009	Subsequent Events
ASC 105	June 2009	The *FASB Accounting Standards Codification* and the Hierarchy of Generally Accepted Accounting Principles—a replacement of FASB Statement No. 162
ASC 820	August 2009	Fair Value Measurements and Disclosures – Measuring Liabilities at Fair Value
ASC 260	September 2009	Earnings per Share – Amendments to Section 260-10-S99
ASC 820	September 2009	Investments in Certain Entities that Calculate Net Asset Value per Share (or Its Equivalent)
ASC 605	October 2009	Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force
ASC 470	October 2009	Accounting for Own-Share Lending Arrangements in Contemplation of Convertible Debt Issuance or Other Financing – a consensus of the FASB Emerging Issues Task Force
ASC 860	December 2009	Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets
ASC 505	January 2010	Accounting for Distributions to Shareholders with Components of Stock and Cash – a consensus of the FASB Emerging Issues Task Force
ASC 810	January 2010	Consolidation (Topic 810): Accounting and Reporting for Decreases in Ownership of a Subsidiary – a Scope Clarification
ASC 718	January 2010	Compensation – Stock Compensation (Topic 718): Escrowed Share Arrangements and the Presumption of Compensation
ASC 820	January 2010	Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements
ASC 855	February 2010	Subsequent Events (Topic 855): Amendments to Certain Recognition and Disclosure Requirements
ASC 810	February 2010	Consolidation (Topic 810): Amendments for Certain Investment Funds
ASC 815	March 2010	Derivatives and Hedging (Topic 815): Scope Exception Related to Embedded Credit Derivatives

Management assessed that the new accounting pronouncements listed above will have a material impact on our financial statements. The Company shall adopt the ASC 605 for revenue recognition of multiple elements arrangement for sales of customized information system software.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE C - RELATED PARTY TRANSACTIONS

Common Shares Issued to Executive and Non-Executive Officers and Directors

As of September 30, 2014, total 20,400,000 shares were issued to officers and directors were not changed. But, the total outstanding shares were changed to 40,104,000; the percentage of common shares issued to executive and non-executive officers and directors have been changed accordingly. Please see the Table below for details:

Name	Title	Share QTY		Amount		Date	% of Common Share*
Zhi Yong Li	Chairman		10,000,000	$	10,000.00	2/19/2008		24.94	%
Wei Wu	President		5,000,000	$	5,000.00	2/19/2008		12.47	%
Hui Tao Zhou	Director		5,000,000	$	5,000.00	2/19/2008		12.47	%
Jian Wu Zhang	Director		100,000	$	3,000.00	3/31/2008		0.25	%
Ming Liu	Director		100,000	$	3,000.00	3/31/2008		0.25	%
Hong Tao Bai	Vice-President		100,000	$	3,000.00	3/31/2008		0.25	%
Nan Su	CTO		100,000	$	3,000.00	3/31/2008		0.25	%
Simon Bai	CFO							0.00	%
Total			20,400,000	$	32,000.00			50.87	%

_____________

* The percentage was based on the total outstanding shares of 40,104,000 as of September 30, 2014.

Loans from Others

In order to continually operation and survive the business, the Company loaned money from shareholders relatives and other friends.

As of September 30, 2014, the balance of loan from others is $141,712. The loans would be repaid as request without interest.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE C - RELATED PARTY TRANSACTIONS (Continue)

Loans from Shareholders

On March 2, 2008, founder of the Company, Mr. Zhiyong Li opened a bank account at Chicago branch with CitiBank. Mr. Zhiyong Li loaned $500.00 to the Company to open the bank account, and the same amount have returned back to him on March, 2009. In the year of 2009, the Company’s founder and CEO, Mr. Zhiyong Li have loaned $53,631 to Beijing subsidiary, Hyperera Technology (Beijing) Co. Ltd for operating and administrating expenses.

In 2010, the Company repaid the loan balance to Mr. Li Zhiyong. As of December 31, 2010, there was travel related expense of $985 paid by Mr. Li Zhiyong, which was accounted as loans from shareholders.

From January to December 31, 2011, Mr. Zhiyong Li advanced additional amount of $6,901 to the Company. The loans would be repaid as request without interest. As of December 31, 2011, the balance of loan from Shareholder was $7,886.

In 2012, Mr. Zhiyong Li advanced additional $24,867 to the Company. Therefore, as of December 31, 2012, the balance of loan from Shareholder was $32,753. The loans would be repaid as request without interest.

In year 2013, the Company returned $ 29,407 to the shareholder. As of December 31, 2013, the balance of loan from Shareholder is $3,346. The loans would be repaid as request without interest.

From January to September 30, 2014, Mr. Zhiyong Li advanced additional amount of $426,543 to the Company. The loans would be repaid as request without interest. As of September 30, 2014, the balance of loan from Shareholder was $429,889.

Loans to Related Party Supplier- Beijing Chaoran

From October to December 2010, the Company advanced short-term loans of $995,836 as of December 31, 2010 to related party supplier, Beijing Chaoran. The interest rate was agreed at annual rate of 3.0%, the repayment terms were demanded as request by the Company.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE C - RELATED PARTY TRANSACTIONS (Continue)

Loans to Related Party Supplier- Beijing Chaoran (Continue)

From January to March 31, 2011, the Company advanced additional short-term loans of $747,500 to related party supplier, Beijing Chaoran. The interest rate was estimated at annual rate of 3%, the accrued interest receivables were $9,273.

On April 15, 2011, Beijing Chaoran returned the loan amount of $1,538,462 to the Company; the Company signed a loan agreement with un-related party Greensaver Corporation to advance loan amount of $1,538,462 at annual interest rate of 10%. The loan term is for short-term 6 months.

As of December 31, 2012, the balance of loan amount to Related Party Supplier-Beijing Chaoran was $5,873, and the interest incomes from Beijng Chaoran were based on annual interest rate of 3% in year 2012

As of December 31, 2013, the balance of loan amount to Related Party Supplier-Beijing Chaoran is $135,232, and the interest incomes from Beijng Chaoran were based on annual interest rate of 3%.

As of September 30, 2014, the balance of loan amount to Related Party Supplier-Beijing Chaoran and the interest incomes that based on annual interest rate of 3% were fully repaid to the Company.

NOTE D - SHAREHOLDERS’ EQUITY

Under the Company’s Articles of Incorporation dated February 19, 2008, the Company is authorized to issue 200,000,000 shares of capital stock with a par value of $0.001.

On Feburary19, 2008, the Company was incorporated in the State of Nevada.

On February 19, 2008, , the Company issued 20,000,000 shares to three founders of the Company, Zhiyong Li, Wei Wu, and Huitao Zhou at $0.001 per share or $20,000 for initial capital (stock subscription receivable). On March 31, 2008, the Company issued total 5,200,000 shares to 52 shareholders at $0.03 per share or $156,000 for common stock (stock subscription receivable). On April 28, 2008, the Company issued additional 1,400,000 shares to 14 shareholders at $0.03 per share or $42,000 for common stock (stock subscription receivable). On July 20, 2008, additional 1,200,000 shares were issued to 7 shareholders at $ 0.03 per share, and the total proceeds of $36,000 were received

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE D - SHAREHOLDERS’ EQUITY (Continue)

On July 20, 2008, 139,000 shares were issued to Williams Law Group at $ 0.03 per share for the legal service value $4,170.

At December 15, 2009, additional 60,000 shares were issued to 3 shareholders, Baozhong Fu, Long Zhang, and Xuefeng Zhang, Chinese citizens, at $ 0.20 per share, and the total proceeds of $12,000 were received.

On September 10, 2010, additional 2,030,000 shares were issued to 79 shareholders, Chinese citizens, at $ 0.20 per share or $ 406,000 for common stock (stock subscription receivable). On December 15, 2010, additional 5,855,000 shares were issued to 70 shareholders at $0.20 per share for $1,171,000. On December 31, 2010, additional 100,000 shares were issued to Mr. Jing Li for financial consulting services at $0.20 per share for $20,000. Therefore, as of December 31, 2010, the Company has a total of 35,984,000 shares were issued and outstanding.

At January 1, 2011, 50,000 shares were issued to one shareholder at $0.20 per share for $10,000. On March 31, 2011, additional 1,660,000 shares were issued to 13 shareholders, Chinese citizens at RMB 1.40 per share, equivalent at USD $0.2153 per share for RMB 2,324,000. At May 1, 2011, 210,000 shares were issued to 8 shareholders at $0.30 per share for $63,000. At June 30, 2011, 200,000 shares were issued to one shareholder at $0.20 per share for $40,000 which was stock subscription receivable as of June 30, 2011.

At July 15, 2011 100,000 shares were issued to one shareholder at $0.45 per share, total proceeds of $45,000 were received on July 2011.

There was no share issued in year 2012.

On July 1, 2013, additional 400,000 shares were issued to 1 shareholder, Chinese citizens, at $ 0.20 per share for $80,000.

On August 30, 2013, additional 1,500,000 shares were issued to 2 shareholders, Chinese citizens, at $ 0.20 per share for $300,000.

There’s no shares issued for the period of September 2013 to September 30, 2014.

Therefore, as of September 30, 2014, the total outstanding common shares were 40,104,000.

HYPERERA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE E - GOING CONCERN

As shown in the accompanying financial statements which have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern, the Company has incurred operating losses of $ 118,493 and $ 128,891 for the fiscal quarter ended September 30, 2014 and 2013 and a cumulative operating loss of $ 1,711,361 for the period February 19, 2008 (inception) through September 30, 2014. The Company is considered to be a development stage company.

The financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern.

The Company’s loans to GreenSaver Corp. of $ 1,538,462 raised substantial doubt about it’s ability to carry out it’s operational business plan and cause uncertainty about its cash flows immediately, such borrows or withdraws may raise substantial doubt about the Company’s ability to continue as going concern immediately. The Company amended the loan agreement with new management of the Greensaver Corp and new management of Greensaver Corp will start paying the principal and interest to the Company over the next 3 years, the loan balance will be paid off by July 31, 2015 based on the amended loan agreement signed on March 2013. Due to GreenSaver Corp is in reorganization under the Chinese laws, there will be uncertainty about the Greesaver Corp. The risk of the loan in default is significant high. If the loan is in default, then the Company will be required to cease or curtail its operation immediately.

There is no guarantee that the Company will be able to raise enough capital or generate revenues to sustain its operations and carry out its business plan. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include adjustments that might result from the outcome of this uncertainty and if the Company is unable to generate significant revenue or secure financing, then the Company may be required to cease or curtail its operation.

Exhibit A
			Three Months Ended		Three Months Ended		Nine Months Ended		Nine Months Ended		February 19, 2008 (Date of Inception) Through
			September 30		September 30		September 30		September 30		September 30,
			2014		2013		2014		2013		2014
Expense
	Auto			6,314		10,952		11,882		11,402		41,947
	Administration Expense			-		-				225		225
	Bank Service Charges			370		416		707		654		4,964
	Computer and Internet Expenses			-		115		-		428		826
	Dues & Subscriptions			-		-		-		-		110
	Depreciation			4,385		4,385		13,155		12,073		51,276
	Employees Welfare Expense			2,403		1,269		7,975		1,269		15,980
	Gift and promotion Expense			-		-				1,758		7,034
	Insurance			7,551		4,733		16,398		8,890		39,513
	License & Registration			-		2,620		474		3,019		15,837
	Meals and Entertainment			1,337		9,344		11,405		9,344		38,225
	Meeting & Conference			1,785		14,654		9,365		14,654		36,699
	Office Supplies			6,280		3,391		29,322		13,359		92,143
	Vehicle and Vessel Usage Tax			-		-		-		-		-
	Telephone Expense			-		252		-		252		1,619
	Utilities			575		536		3,388		1,362		19,422
	Bank interest			-		-		-		5		-
	Purchase of Bank Note			-		-		-		-		-
	Small tools and equipment			-		-		-		-		150
	Supplies			-		-		-		-		1,307
	Postage			1,819		399		2,403		476		4,939
	Payroll Expenses			54,193		43,848		171,838		78,776		475,225
	Professional Fees
		Accounting and Auditing		-		2,308		25,645		27,923		136,089
		Consulting Fees		-		-		-		-		102,741
		Legal Fee		11,300		-		23,365		15,300		131,918
		SEC filling fee		-		1,643		3,036		5,283		39,375
		Professional Fees - Other		3,381		1,580		4,381		1,880		74,180
	Professional Fees			14,681		5,530		56,426		50,386		484,303
	Rent Expense			23,172		15,933		69,517		40,521		292,171
	Tax-China Operation			728		-		728		-		12,194
	Research & development expense			-		-		-		-		3,960
	Travel Expense
	Travel Expense			5,635		10,513		18,048		11,598		104,892
	Sales Expense			44,493		-		44,493		-		44,493
Total Expense				175,720		128,891		467,523		260,452		1,789,452

Item 2. Management’s Discussion and Analysis or Plan of Operation.

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include specifically the risk that the Greensaver loan as described below in Loans to Greensaver Corporation may not be repaid in whole or in part as further described in this subsection and related opinion filed in our Form 10-K for the fiscal year ended December 31, 2013 and additional information from China counsel set forth in that opinion, as updated, as well as the late payments from Hunan Great Wall Medical Co., Ltd. as described below.

Although the forward-looking statements in this Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

Overview

Existing Business

Our initial business was the sale of hardware and software and the customization of clinical information system software for medical clinics and hospitals in China and throughout Asia. We have been developing our infrastructure to begin marketing clinical information system software and hardware. We have generated sales revenues $13,785.50 for the three months period ended September 30, 2014, and cumulative revenue of $242,644 from date of inception February 19, 2008 to September 30, 2014. We have begun to advance our business due to past and continuing significant effort and thus we did record revenues in the second quarter ended September 30, 2014.

The Clinical Information System was developed in China by Beijing Chaoran Chuangshi Technology Co., Ltd (“Beijing Chaoran”). It was established in 2002 specializing in technology developed and service, sales of computer hardware and software, machine and electric equipment. Beijing Chaoran is located in No.28 Mujiu Road, Mujiayu Town, Miyun, Beijing, China. Beijing Chaoran is a Chinese Technology company owned 100% by Mr.Liancheng Li, the father of our Chairman Zhi Yong Li.

We signed a three-year software distribution agreement with Beijing Chaoran on March 1, 2009. Under the terms of the agreement Beijing Chaoran authorizes Hyperera to be its exclusive sales and service agent for surgery anesthesia clinic management software and ICU management system product lines. The product lines shall include the products that Beijing Chaoran developed before the agreement signed and the products that will be developed by Beijing Chaoran during the term of the agreement. Beijing Chaoran is the exclusive supplier of the products Hyperera sells.

The purchase price Hyperera will pay for all products subject to this agreement will be comparable to what Hyperera would have paid a non-related party in arm’s-length transactions. Specifically, the selling price for Beijing Chaoran is determined by total actual cost of direct materials (hardware), direct labor, and allocated overhead, plus 5-10% of Beijing Chaoran’s total purchase cost if Beijing Chaoran resells to Hyperera.

Our operations depend heavily on the continuation of our distribution agreement with Beijing Chaoran. The agreement with Beijing Chaoran was originally for a term of three years commencing March 1, 2009, subject to earlier termination upon terms described in the Agreement. We orally agreed to extend the Agreement for three additional years upon the same terms and conditions. Although we believe such events are not likely, if they were to occur, we may not be able to find alternative suppliers if the agreement is terminated or not renewed which could reduce our revenues or cause us to cease operations.

We have continued to encounter difficulties in marketing this product but our efforts are continuing. We’ve hired another 6 employees and rented a new office to continue the project of the sale of hardware and software and the customization of clinical information system software for medical clinics and hospitals. We are planning to sell the software of Mobile Nurse Station, Mobile Healthcare and Impatient System in China and sell relevant equipment relating to the above systems. The research and development is completed however we have made no sales and no assurance can be given if or when we would make sales.

In this quarter, we made some adjustments in personnel, as follows: We fired 3 engineers and a graphic designers, because they are shown not suitable for our business in the probation period. Now we hired 3 new engineers and a sales staff for the Mobile Nurse Station, Mobile Healthcare, the new project and the future market development as described below, specifically the electronic medical record, Hospital clinical information system, Intelligent infusion system and a kind of customized version of the Hyperera Medical Intelligent Patrol Box as described below.

We developed relationships with a number of new supplier for components for in hardware sales. We have signed a Purchase Contract Framework with ETcomm (Beijing) Science & Technology Co., Ltd, which is filed as an exhibit to this Quarterly Report on Form 10-Q, which exhibit should be referred to in its entirety with respect to its terms and conditions. We have bought two set of the hardware products for "Hyperera Medical Intelligent Patrol Box” from ETcomm as a sample, and we expect to purchase 5000 sets of hardware products for "Hyperera Medical Intelligent Patrol Box” in the future. We intend to purchase 5000 sets in one year one after another, and these hardware products are going to be used for the Jilin project described below.

We continue our plans to start sell "Hyperera Medical Intelligent Patrol Box” to Heilongjiang province and the Inner Mongolia Autonomous Region, as well as promoting “Intelligent infusion system.” However, as of the date of this Report, we have no formal contracts for sales of these products and may never receive formal contracts or make sales.

In February 2014, Hyperera and Sichuan Province Information Institute of Medicine (Sichuan Province Health Information Center) reached an agreement on the collaborative development of Deyang regional health information platform (research) project (“Deyang RHIE Project”). However, due to issues with the other party to this agreement, this project may never be able to move forward and we may never develop a product or generate any revenues.

Our agreement with Caradigm described in prior filings expired and was not renewed.

Updates on developments previously described in our in Report on Form 10-Q for our six month period ended June 30, 2014 are as follows:

Hyperera Medical Intelligent Patrol Box

WE PREVIOUSLY REPORTED THE FOLLOWING: During the second quarter the Company focused on development of a new product "Hyperera Medical Intelligent Patrol Box." Hyperera Medical Intelligent Patrol Box is designed for the general practitioner. It is a collection of several small mobile medical service station Point of Care Testing ("POCT") devices, including vital signs analyzer, urine analyzer, blood glucose meter, portable ECG monitor, pulse oxygen equipment, medical blood pressure monitor and a series screening equipment against common diseases, chronic diseases and frequently-occurring diseases. It is being designed to meet the need for diagnosis and treatment of general practitioners in the community, countries, village clinics, first aid or other places. Except for the basic configuration, Hyperera Medical Intelligent Patrol Box can be set up personalized according to different needs of users. Hyperera has begun to acquire various components of this product but the product is not finished and not yet ready for sale. We anticipate that we will be able to begin sales of this device in the near future but cannot give an exact date at this time.

·	UPDATE: In this quarter, the company has signed a formal contract with Jilin Province which is filed as an exhibit to this filing. The material terms of this agreement between Party A: Health Information Institute of Jilin Province and Party B: Hyperera Technology (Beijing) Ltd. are as follows:

Party A plans to install and agreed to purchase 5400 sets of "Hyperera Medical Intelligent Patrol Box" to the whole province within one year, a monthly average of 450 sets of installation, at the price of ￥19600 ($3161.29) every set. Party B will send Hyperera Medical Intelligent Patrol Box to a location which was designated by Party A, after acceptance, installation and commissioning, according to the actual confirmation sets, Party A will make payments quarterly as required under the agreement. It is anticipated funding will be provided as follows: According to the related policy of the government, Party A guarantees implement the financial support for basic public health service fund of the government, according to a standard of not less than ￥3 ($0.48) per person, with a portion retained by Party A and the remainder used to purchase product from Party B. The term of the contract is three years.

CURRENT STATUS: We are doing Software Programming work for the "Hyperera Medical Intelligent Patrol Box", and already schedule a purchase of 200 sets hardware of the "Hyperera Medical Intelligent Patrol Box" from ETcomm (Beijing) Science & Technology Co., Ltd, and now the hardware is in production. Nothing has been sent to the Health Information Institute of Jilin Province. A purchase order for these 200 sets was signed in December 2014 with ETcomm, and the 200 sets of delivery time is December after we pay the remaining amounts due.

Agreement with Yanqing County Hospital

An agreement with Yanqing County Hospital (a county hospital in Beijing) was established and signed in the prior quarter. Yanqing County Hospital bought Hyperera wireless mobile information system software V1.0- wireless mobile outpatient infusion system and the corresponding technical services. The amount of the contract is 100,000 yuan. We have now received the payment ￥100000 ($16,129.03) in this quarter, and the project has ended. Of the $16,129.03, we recorded $13,785.50 as revenue and the remaining of $2,343.53 expensed as value added tax payable to Chinese government.

OTHER PROJECTS

Medical Payment Adaptor to Hunan Great Wall Medical Technology Co., Ltd.

During our first quarter, Hyperera entered into a contract to sell a kind of medical payment adaptor to Hunan Great Wall Medical Technology Co., Ltd. The amount of the contract with Hunan Great Wall Medical Co., Ltd. is 860,000 yuan or approximately USD $139,976. The project name is interface modification of HIS system. Hyperera has finished all work required of it under the agreement and payment is due. Although management believes payment will be received in the near future, payment was not received when due, was not received last quarter or this quarter, nor as of the date of filing of this Report, and we can give no assurance if or when it will be received

Sunbase International (Holdings) Limited

A strategic co-operation framework agreement between Hyperera and Sunbase International (Holdings) Limited (Sunbase Holdings) signed on July 7, 2014 in Hong Kong. Under this contract Hyperera and Sunbase Holdings agree to joint develop the "WIT120" relative integrated solutions in the fields of hardware and software. The Agreement provides as follows: Both parties agreed on a project cost ceiling of 20 billion yuan, but the agreement does not specify any time or requirement of either party to do this. The WIT120 is a regional health information platform system that helps manage the following.

·	Maternal and Child Health Management Systems
·	residents' health records management system
·	the CDC Emergency Command System
·	infectious disease reporting system
·	chronic disease management system

·	population information database system
·	the new rural cooperative information system
·	the digital hospital information system
·	primary health care system
·	food and medicine / health supervision and management system
·	smart medical devices

We have made no sales of this product and may never make any sales from this product.

During our third quarter ended September 30, 2014, we commenced negotiations on a “Capital Institute of Pediatrics Hospital Project” with which we anticipate working jointly with Microsoft Corp. We have no formal contracts, agreements or commitments with or from either party and we may never have any formal contracts, agreements or commitments. There is no assurance that this project will ever begin or if it does will ever produce revenues or profits.

GREENSAVER LOAN: Greensaver Corp. promised to pay back￥50,000 in the second quarter of 2014 and payment was received. They also promised to pay back ￥50,000 in the third quarter of 2014. As of the date of this filing, this payment has not been received. The loan agreement signed before is still in process of negotiation. See Loans to Greensaver Corporation, below for further information about this problematic loan transaction.

Results of Operations

For the third quarter ended September 30, 2014 vs. September 30, 2013.

Revenue

For the third quarter ended September 30, 2014 and 2013, the Company had $0.00 revenue for hardware sales respectively.

For the third quarter ended September 30, 2014, and 2013, there were software sale and installation service of $13,786, and $0.00, respectively.

Cost of Revenue

All the products sold in the past were purchased from Beijing Chaoran. For the third quarter ended September 30, 2014 and 2013, the Company incurred zero cost of goods sold for hardware.

For the third quarter ended September 30, 2014, and 2013, there were $3,852 and $0.00 software cost of goods sold incurred, respectively.

Expense

For the third quarter ended September 30, 2014, the Company incurred selling, general and administrative expenses, and depreciation expense of $175,720. The primary expenses were professional fee of $14,681, rental expense of $23,172, payroll expense of $54,193, and sales marketing expense of $44,493.

For the third quarter ended September 30, 2013, the Company incurred selling, general and administrative expenses and depreciation expense of $128,891.

For the third quarter ended September 30, 2014 vs. September 30, 2013, the increase of operating expense is due to the increase of sales and marketing activities as well as hireing more IT professionals and marketing staff.

The Company is still development stage enterprise and need to secure financing activities to survive. As the Company was in the progress of building up the network relations and promotion of Hyperera’s name and its products, the Company incurred significant increase of overall selling, general and administrative expenses.

Income Taxes

There were no income taxes.

Net Loss

For third quarter ended September 30, 2014, the Company had net loss of $165,603; for third quarter ended September 30, 2013, the Company incurred net loss of $89,355. At September 30, 2014, the Company had accumulated net loss of $1,313,046 for cumulative period from February 19, 2008 (Date of Inception) through September 30, 2014.

For the nine month period ended September 30, 2014 vs. September 30, 2013.

Revenue

For the nine month period ended September 30, 2014 and 2013, the Company had $0.00 revenue for hardware sales respectively.

For the nine month period ended September 30, 2014, and 2013, there were software sale and installation service of $13,786, and $0.00, respectively.

Cost of Revenue

All the products sold were purchased from Beijing Chaoran. For the nine month period ended September 30, 2014 and 2013, the Company incurred zero cost of goods sold for hardware.

For the nine month period ended September 30, 2014, and 2013, there were $3,852 and $0.00 software cost of goods sold incurred, respectively.

Expense

For the nine month period ended September 30, 2014, the Company incurred selling, general and administrative expenses, and depreciation expense of $467,523. The primary expenses were professional fee of $56,426, rental expense of $69,517, office supplies of $29,322, payroll expense of $171,838, and sale marketing expense of $44,493.

For the nine month period ended September 30, 2013, the Company incurred selling, general and administrative expenses and depreciation expense of $260,452.

For the nine month period ended September 30, 2014 vs. September 30, 2013, the increase of operating expense is due to the increase of sales and marketing activities as well as hireing more IT professionals and marketing staff.

Income Taxes

There were no income taxes.

Net Loss

For nine month period ended September 30, 2014, the Company had net loss of $456,830; for nine month period ended September 30, 2013, the Company incurred net loss of $142,948. At September 30, 2014, the Company had accumulated net loss of $1,313,046 for cumulative period from February 19, 2008 (Date of Inception) through September 30, 2014.

Commitments and Contingencies

Our Company is still a development stage enterprise, and we continue to expend our efforts in our marketing to sell our software. However, we have met unanticipated significant market resistance to our software because its current technological stage of development. Further, due to most of our potential customers are state-owned hospitals, we incurred significant difficulty to go through the lengthy governmental approval process. We continue to explore methods to improve our product and remedy this situation. We believe our activities in the quarter ended September 30, 2014 described above demonstrate how we continue to move forward to advance our business despite these difficulties.

We continue to be unable to secure repayment of our significant loan to Greensaver Corporation, and yet again another payment deadline has passed with no repayment. See discussion of “Loans to Greensaver Corporation” below for a more complete discussion of the current status of this matter.

Loans to Related Party Supplier- Beijing Chaoran

From October to December 2010, the Company advanced short-term loans of $995,836 as of December 31, 2011 to supplier, Beijing Chaoran. The interest rate was agreed at annual rate of 3.0%, the accrued interest receivables were $3,127. The repayment terms were upon demand as request by the Company.

From January to March 31, 2011 the Company advanced additional short-term loans of $747,500 to supplier, Beijing Chaoran. The interest rate was estimated at annual rate of 3%, the accrued interest receivables were $9,273.

On April 14, 2011, Beijing Chaoran repaid the loan amount of $1,538,462 to the Company; the Company signed a loan agreement with unrelated party Greensaver Corporation to advance loan amount of $1,538,462 at annual interest rate of 10%.

As of December 31, 2013, the balance of loan amount to Related Party Supplier-Beijing Chaoran is $135,232, and the interest incomes from Beijng Chaoran were based on annual interest rate of 3%.

As of September 30, 2014, the balance of loan amount to Related Party Supplier-Beijing Chaoran and the interest incomes that based on annual interest rate of 3% were fully repaid to the Company.

Loans to Greensaver Corporation

On April 14, 2012, the Company through its subsidiary Hyperera Technology (Beijing) Co., Ltd. signed a loan agreement with unrelated party Greensaver Corporation to advance a loan amount of $1,538,462 [10,000,000 RMB] at annual interest rate of 10%. The loan agreement was amended on March 2013 as follows:

The status of our relationship with Greensaver Corporation as of September 30, 2013 is as follows:

	(1)	The loan agreement was amended and extended to December 31, 2015;

	(2)	Because Greensaver is incapable to repay the loan, the loan amount plus interest was paid only once at January 2013 for total RMB 500,000 by Greensaver as of today. The loan agreement was amended on March 2013 to provide for a monthly payment of $80,645 starting July 1, 2013 and continuing until the loan is paid off by December 31, 2015.

In December 2013, owing to suddenly monetary tightening in China, the state loan was temporarily shelved, Greensaver failed to resume production. In addition, some of the creditors sued it, resulting in funds not being in place on schedule, and Greensaver’s inability to timely repay the company's debt. Based on the above situation, although we could sue for Greensaver, we prefer to receive the loan repayment without lawsuit. Our Loan Agreement has been subsequently amended as follows:

Greensaver Corp. promise:

Pay back ￥50,000 in the second quarter of 2014, which was paid, but late.

Pay back ￥150,000 in the third quarter of 2014, which has not been paid for the reasons set forth above.

Pay back ￥300,000 in the fourth quarter of 2014.

From the beginning of 2015 to repay ￥2.5 million per quarter, by the end of 2015 to repay all principal and interest payable (calculated at an annual rate of 10%)

Greensaver Corp.

(Seal)

[1 Chinese Yuan equals $0.16 US Dollar as of May 12, 2014.]

The Company has been involved in on-going discussions concerning this matter and if the Company has signed anything binding which changes or modifies the foregoing, it will file a Form 8-K concerning such matter.

However, because of the continuing difficulties in collecting on this loan, the Company asked Chinese legal counsel to furnish a legal opinion as to the status of this loan. This opinion has been filed as an exhibit to our Form 10-K for the fiscal year ended December 31, 2013 along with the Amended Greensaver Agreement. Chinese counsel consented to the opinion being attached to the Form 10-K in writing and to a discussion of the opinion and subsequent correspondence with the Company’s US legal counsel. In essence, China legal counsel indicates that it is his opinion that the Amendment is valid and lawful and that the Company still has a valid claim to the principal amount of the loan. In a subsequent e-mail to US counsel, China counsel indicated: “Regarding the chance of collection for Hyperera, on the base of present conditions, it is impossible to give a accurate rate of chance of collection. But I can confirm that there is a reasonable likelihood that Hyperera will have chance to collect part or whole loan on the claim.”

We asked the attorney to update his position on the status of this loan. On November 14, 2014, he wrote the Company as follows:

Greensaver and debtors signed the Minutes of Debtor Meeting on Sep.14, 2014, with a repayment schedule stated. However, up to the present, Greensaver has not make the first payment due in October, 2014. Under the minutes of meeting and current status, on the respect of law, Hyperera still has a legal and valid claim to the principal amount of the loan. Concerning the rate of chance of collection, it depends mainly on the consequence of restructure of Greensaver’s assets.

Based upon the history of this transaction and the current position of the China lawyer set forth above, the Company urges any investor making an investment decision in the stock of the company to exercise extreme caution if that decision is based in any in in whole or in part, no matter how small the part, on the assumption that the Company will ever collect anything on this loan.

Liquidity and Capital Resources

	At September 30			At December 31
	2014			2013

Current Ratio		0.32			1.11
Cash	$	117,252		$	129,009
Working Capital	$	(410,050	)	$	28,263
Total Assets	$	1,742,509		$	1,846,336
Total Liabilities	$	602,468		$	248,068

Total Equity	$	1,140,061		$	1,598,268

Total Debt/Equity		0.53			0.16

*Current Ratio = Current Assets / Current Liabilities

**Total Debt / Equity = Total Liabilities / Total Shareholders’ Equity.

***Working Capital = Current Assets – Current Liabilities

The Company had cash and cash equivalents of $117,252 at September 30, 2014 and the negative working capital of $410,050, and cash and cash equivalent of $129,009 at December 31, 2013 and the working capital of $28,263.

The Company’s related party transactions, the short-term loans to related party supplier, may raise substantial doubt about its ability to carry out its operational business plan and cause uncertainty about its cash flows, such related party borrows or withdraws may raise substantial doubt about the Company’s ability to continue as going concerns.

Conclusion

Shareholder’s Equity

The Company had total equity of $1,598,268 at September 30, 2014, and $1,814,836 at September 30, 2013 respectively

On February 19, 2008, the Company issued 20,000,000 shares to six founders of the Company, Zhiyong Li, Wei Wu, and Huitao Zhou at $0.001 per share or $20,000 for initial capital (stock subscription receivable). On September 30, 2008, the Company issued total 5,200,000 shares to 52 shareholders at $0.03 per share or $156,000 for common stock (stock subscription receivable). On April 28, 2008, the Company issued additional 1,400,000 shares to 14 shareholders at $0.03 per share or $42,000 for common stock (stock subscription receivable). On July 20, 2008, additional 1,200,000 shares were issued to 7 shareholders at $ 0.03 per share, and the total proceeds of $36,000 were received.

On July 20, 2008, 139,000 shares were issued to Williams Law Group at $ 0.03 per share for the legal service value $4,170.

At December 15, 2009, additional 60,000 shares were issued to 3 shareholders, Baozhong Fu, Long Zhang, and Xuefeng Zhang, Chinese citizens, at $0.20 per share, and the total proceeds of $12,000 were received.

On September 10, 2010, additional 2,030,000 shares were issued to 79 shareholders, Chinese citizens, at $0.20 per share or $406,000 for common stock (stock subscription receivable). On December 15, 2010, additional 5,855,000 shares were issued to 70 shareholders at $0.20 per share for $1,171,000. On December 31, 2010, additional 100,000 shares were issued to Mr. Jing Li for financial consulting services at $0.20 per share for $20,000. Therefore, as of December 31, 2010, the Company has a total of 35,984,000 shares were issued and outstanding.

At January 1, 2011, 50,000 shares were issued to one shareholder at $0.20 per share for $10,000. On September 30, 2013, additional 1,660,000 shares were issued to 13 shareholders, Chinese citizens at RMB 1.40 per share, equivalent at USD $0.2153 per share for RMB 2,324,000. At May 1, 2011, 210,000 shares were issued to 8 shareholders at $0.30 per share for $63,000. At September 30, 2013, 200,000 shares were issued to one shareholder at $0.20 per share for $40,000 which was stock subscription receivable as of September 30, 2013.

At July 15, 2011 100,000 shares were issued to one shareholder at $0.45 per share, total proceeds of $45,000 were received on July 2011.

There was no share issued in year 2013.

On July 1, 2013, additional 400,000 shares were issued to 1 shareholder, Chinese citizens, at $ 0.20 per share for $ 80,000.

On August 30, 2013, additional 1,500,000 shares were issued to 2 shareholders, Chinese citizens, at $ 0.20 per share for $ 300,000.

Therefore, as of September 30, 2014, the total outstanding common shares were 40,104,000.

Item 3. Quantitative and Qualitative Disclosure about Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act) that are designed to ensure that information required to be disclosed in the Company’s Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective.

Changes in Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Securities Exchange Act) during the fiscal quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

Exhibit No.		Document Description

10.1		Cooperation Agreement of Basic Public Health Service Items in Jilin Province [Translated Copy]

10.2		Contract Framework with ETcomm (Beijing) Science & Technology Co., Ltd

31.1		CERTIFICATION of CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

31.2		CERTIFICATION of CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

32.1 *		CERTIFICATION of CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002.

32.2 *		CERTIFICATION of CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002.

Exhibit 101		Interactive data files formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to the Consolidated Financial Statements.**

101.INS		XBRL Instance Document**

101.SCH		XBRL Taxonomy Extension Schema Document**

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document**

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document**

101.LAB		XBRL Taxonomy Extension Label Linkbase Document**

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document**

____________

* This exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Hyperera, Inc., a Nevada corporation

Title	Name	Date	Signature

Principal Executive Officer	Zhi Yong Li	December 23, 2014	/s/ Zhi Yong Li

In accordance with the Exchange Act, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURE	NAME	TITLE	DATE

/s/ Zhi Yong Li	Zhi Yong Li	Principal Executive Officer and Director	December 23, 2014

/s/ Simon Bai	Simon Bai	Principal Financial Officer and	December 23, 2014
		Principal Accounting Officer

EXHIBIT INDEX

Exhibit No.		Document Description

10.1		Cooperation Agreement of Basic Public Health Service Items in Jilin Province [Translated Copy]

10.2		Contract Framework with ETcomm (Beijing) Science & Technology Co., Ltd

31.1		CERTIFICATION of CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

31.2		CERTIFICATION of CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

32.1 *		CERTIFICATION of CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002.

32.2 *		CERTIFICATION of CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002.

Exhibit 101		Interactive data files formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to the Consolidated Financial Statements.**

101.INS		XBRL Instance Document**

101.SCH		XBRL Taxonomy Extension Schema Document**

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document**

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document**

101.LAB		XBRL Taxonomy Extension Label Linkbase Document**

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document**

____________

HYPERERA INC 10-Q